Trademark Search  /  CARIS MOLECULAR TUMOR BOARD REPORT

CARIS MOLECULAR TUMOR BOARD REPORT

● Live · Pending

U.S. federal trademark · Serial No. 99701221

Mark
CARIS MOLECULAR TUMOR BOARD REPORT
Status
Pending
Serial Number
99701221
Filing Date
March 13, 2026
Class(es)
Class 042, Class 044

Owner

Caris MPI, Inc.
03 · Irving, TX, US

Goods & Services

Providing medical and scientific research information to researchers, patients and medical professionals in the form of reports in the field of molecular profiling for the characterization of cancer, genomic and transcriptomic characteristics, tumor microenvironment, and determination of biosignatures using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on molecular profiling, including next-generation sequencing (NGS) such as whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)

Providing medical information to patients and medical professionals in the form of reports in the field of molecular profiling for the diagnosis, treatment and monitoring of cancer using bioinformatics and artificial intelligence; providing medical research information in the field of cancer based on molecular profiling, including next-generation sequencing (NGS) such as whole exome sequencing (WES), whole transcriptome sequencing (WTS), and whole genome sequencing (WGS)

Thinking of using a similar name?
Search 14 million+ trademarks free and see if your brand conflicts with "CARIS MOLECULAR TUMOR BOARD REPORT" or anything like it, before you file.
Run a free trademark search →

Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.